Robeco Healthy Living I Cap EUR

Rating and Score  (On 30/06/2026)
Rating
FIDA
Rating
ESG
***Some functions are not available in this version.***
Register for free to unlock functions
Static data
Name
Robeco Healthy Living I Cap EUR
Typology
Funds and Sicav
ISIN Code
LU2146190165
Sicav
Robeco Capital Growth Funds
Registration country
-
Country authorised for sale
Asset manager
Address
Weena 850 NL-3014 Rotterdam
Phone
Web site
FIDA Category
Assogestioni category
EFAMA Category
Equity Health Care
Priips
Yes
Official benchmark
100.00% - MSCI World Net TR (EUR)
Start Date placement
30/10/2020
Search by currency
Eur - euro
Quotation currency
Eur - euro
Status
Active
Distribution policy
No
Total asset value at 30/07/2026
-
Assets of portfolio as of 30/07/2026
130.12 mln EUR
Documentation
Quotation evolution (From 28/07/2023 On 30/07/2026)
273.55
3.14
%
30/07/2026
Loading data
Quote
Quotation currency
Eur - euro
Quotation frequency
Daily
Last quotation
€273.55 (30/07/2026)
% change
-1.70%
Last Price in Euro
€273.55
Investment Objective
Robeco Healthy Living is an actively managed fund that invests globally in companies that promote good health and well-being and contribute to an efficient healthcare system including also products or services linked to the prevention of disease via eating healthier diets, exercising regularly and reducing the spread of infectious diseases with hygiene measures. The selection of these stocks is based on fundamental analysis. The fund has sustainable investment as its objective, within the meaning of Article 9 of the Regulation (EU) 2019/2088 of 27 November 2019 on Sustainability-related disclosures in the financial sector. The fund's objective is also to achieve a better return than the Benchmark. The strategy integrates sustainability criteria as part of the stock selection process and through a theme-specific sustainability assessment. The portfolio is built on the basis of an eligible investment universe that includes companies whose business models contribute to the thematic investment objectives. The assessment regarding relevant SDGs uses an internally developed framework, more information on which can be obtained at www.robeco.com/si. The fund has sustainable investment as its objective within the meaning of Article 9 of the European Sustainable Finance Disclosure Regulation. The fund aims to mitigate the rising incidence of lifestyle diseases and increasing healthcare costs, by investing in companies that provide technologies, products or services, medical treatments linked to the prevention of disease and reducing the spread of infectious diseases. This is done by investing in companies that mainly advance the following UN Sustainable Development Goals (UN SDGs): Good health and well-being, Zero Hunger, and Clean water and sanitation. The fund integrates ESG (Environmental, Social and Governance) factors in the investment process and applies Robeco's Good Governance policy. The fund applies sustainability indicators, including but not limited to, normati
Tax system
PIR compliant
No
PEA compliant
No
PEA-PME compliant
No
Company registry
Asset manager
Phone
Web site
Address
Weena 850 NL-3014 Rotterdam
The data and information covered by the Service are for the exclusive internal use of the User and may neither be transferred to third parties, nor circulated, disclosed or allowed to be disclosed, nor used on external information systems, without the written consent of FIDA and, when necessary, of the information sources.
Logo FIDA